INSIGHTS ON CLINICAL TRIAL PARTNERING

• Site Engagement Improves Study Support And Results

  Dedicated site engagement helps reduce administrative burden, improve participant access, and keep studies moving. This approach strengthens workflows and supports sites throughout every phase.

• eCOA Standards And KPIs To Include In Your Next RFI

  Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.

• Early Phase Clinical Trial Enrollment: How To Avoid Delays From The Start

  By operationalizing the early-phase strategies discussed in this article, trial teams can ensure that foundational safety and efficacy data are captured without the delays that derail studies.

• The Founder Behind The Platform

  Learn about the founding and mission of ClinAI, a groundbreaking platform that leverages automation and analytics to enhance vendor selection and management.

• Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule

  1/22/2026

  Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.

• Building One Home for Sites

  7/23/2024

  Watch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.

• Mastering Precision Oncology Start-Up: Reducing Screening Delays

  3/30/2026

  Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.

• Breaking Down Operational And Financial Complexity In Clinical Trials

  12/8/2025

  Consider how factors like hybrid visits, enrollment patterns, and variable procedure volumes shape both the cadence and magnitude of site payments, supplier activity, and patient-related expenses.

• Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them

  10/21/2025

  Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.